Synergy CHC Corp. Operating Expenses
Synergy CHC Corp. (SNYR) reported Operating Expenses of $4.54 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-05-14
- Synergy CHC Corp. operating expenses for the quarter ending 2026-03-31 was $4.54M, a 7.63% increase year-over-year.
- Synergy CHC Corp. operating expenses for the quarter ending 2025-12-31 was $15.53M, a 201.93% increase year-over-year.
- Synergy CHC Corp. operating expenses for the quarter ending 2025-09-30 was $4.40M, a 17.68% increase year-over-year.
- Synergy CHC Corp. operating expenses for the quarter ending 2025-06-30 was $4.61M, a 15.59% increase year-over-year.
- Synergy CHC Corp. operating expenses for fiscal 2025 was $28.76M, a 61.20% increase from fiscal 2024.
- Synergy CHC Corp. operating expenses for fiscal 2024 was $17.84M, a 16.13% decline from fiscal 2023.
- Synergy CHC Corp. operating expenses for fiscal 2023 was $21.27M.
- Synergy CHC Corp. operating expenses for fiscal 2019 was $28.18M, a 1.70% increase from fiscal 2018.
| Period end | Operating Expenses 3 month | Operating Expenses 5 month | Operating Expenses 5 month as first filed | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month | Operating Expenses 12 month as first filed | Operating Expenses 28 month | Operating Expenses 31 month | Operating Expenses 34 month | Operating Expenses 37 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $4.54M 10-Q · filed 2026-05-14 | $20.07M derived: sum of 2 quarters · filed 2026-05-14 | $24.47M derived: sum of 3 quarters · filed 2026-05-14 | $29.08M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2025-12-31 | $15.53M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $19.93M derived: sum of 2 quarters · filed 2026-04-01 | $24.55M derived: sum of 3 quarters · filed 2026-04-01 | $28.76M 10-K · filed 2026-04-01 | |||||||
| 2025-09-30 | $4.40M 10-Q · filed 2025-11-13 | $9.02M derived: sum of 2 quarters · filed 2025-11-13 | $13.23M 10-Q · filed 2025-11-13 | $18.38M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2025-06-30 | $4.61M 10-Q · filed 2025-08-14 | $8.83M 10-Q · filed 2025-08-14 | $13.97M derived: sum of 3 quarters · filed 2026-05-14 | $17.71M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2025-03-31 | $4.22M 10-Q · filed 2026-05-14 | $9.36M derived: sum of 2 quarters · filed 2026-05-14 | $13.10M derived: sum of 3 quarters · filed 2026-05-14 | $17.09M derived: sum of 4 quarters · filed 2026-05-14 | |||||||
| 2024-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-01 | $8.88M derived: sum of 2 quarters · filed 2026-04-01 | $12.88M derived: sum of 3 quarters · filed 2026-04-01 | $17.84M 10-K · filed 2026-04-01 | |||||||
| 2024-09-30 | $3.74M 10-Q · filed 2025-11-13 | $7.73M derived: sum of 2 quarters · filed 2025-11-13 | $12.70M 10-Q · filed 2025-11-13 | $19.14M derived: sum of 4 quarters · filed 2025-11-13 | |||||||
| 2024-06-30 | $3.99M 10-Q · filed 2025-08-14 | $8.96M 10-Q · filed 2025-08-14 | $15.40M derived: sum of 3 quarters · filed 2025-08-14 | $21.03M derived: sum of 4 quarters · filed 2025-08-14 | |||||||
| 2024-03-31 | $4.97M 10-Q · filed 2025-05-15 | $11.41M derived: sum of 2 quarters · filed 2025-05-15 | $17.04M derived: sum of 3 quarters · filed 2025-05-15 | ||||||||
| 2023-12-31 | $6.45M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $12.07M derived: sum of 2 quarters · filed 2025-03-31 | $21.27M 10-K · filed 2025-03-31 | ||||||||
| 2023-09-30 | $5.63M 10-Q · filed 2024-12-06 | $14.83M 10-Q · filed 2024-12-06 | |||||||||
| 2020-03-31 | $3.61M 10-Q · filed 2020-06-29 | $18.15M derived: sum of 2 quarters · filed 2020-06-29 | $22.66M derived: sum of 3 quarters · filed 2020-06-29 | $26.69M derived: sum of 4 quarters · filed 2020-06-29 | |||||||
| 2019-12-31 | $14.54M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $19.05M derived: sum of 2 quarters · filed 2020-04-29 | $23.07M derived: sum of 3 quarters · filed 2020-04-29 | $28.18M 10-K · filed 2020-04-29 | |||||||
| 2019-09-30 | $4.51M 10-Q · filed 2019-11-14 | $8.53M derived: sum of 2 quarters · filed 2019-11-14 | $13.64M 10-Q · filed 2019-11-14 | $22.20M derived: sum of 4 quarters · filed 2020-06-29 | |||||||
| 2019-06-30 | $4.02M 10-Q · filed 2019-08-13 | $9.13M 10-Q · filed 2019-08-13 | $17.68M derived: sum of 3 quarters · filed 2020-06-29 | $23.29M derived: sum of 4 quarters · filed 2020-06-29 | |||||||
| 2019-03-31 | $5.11M 10-Q · filed 2020-06-29 | $13.66M derived: sum of 2 quarters · filed 2020-06-29 | $19.27M derived: sum of 3 quarters · filed 2020-06-29 | $26.35M derived: sum of 4 quarters · filed 2020-06-29 | |||||||
| 2018-12-31 | $8.56M derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-29 | $14.16M derived: sum of 2 quarters · filed 2020-04-29 | $21.24M derived: sum of 3 quarters · filed 2020-04-29 | $27.71M 10-K · filed 2020-04-29 | $26.27M 10-K · filed 2019-03-29 | ||||||
| 2018-09-30 | $5.61M 10-Q · filed 2019-11-14 | $12.69M derived: sum of 2 quarters · filed 2019-11-14 | $19.15M 10-Q · filed 2019-11-14 | $24.96M derived: sum of 4 quarters · filed 2019-11-14 | |||||||
| 2018-06-30 | $7.08M 10-Q · filed 2019-08-13 | $13.54M 10-Q · filed 2019-08-13 | $19.35M derived: sum of 3 quarters · filed 2019-08-13 | $25.42M derived: sum of 4 quarters · filed 2019-08-13 | |||||||
| 2018-03-31 | $6.47M 10-Q · filed 2019-05-03 | $12.27M derived: sum of 2 quarters · filed 2019-05-03 | $18.34M derived: sum of 3 quarters · filed 2019-05-03 | $25.29M derived: sum of 4 quarters · filed 2019-05-03 | |||||||
| 2017-12-31 | $5.81M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $11.88M derived: sum of 2 quarters · filed 2019-03-29 | $18.83M derived: sum of 3 quarters · filed 2019-03-29 | $23.96M 10-K · filed 2019-03-29 | |||||||
| 2017-09-30 | $6.07M 10-Q · filed 2018-11-13 | $13.02M derived: sum of 2 quarters · filed 2018-11-13 | $18.15M 10-Q · filed 2018-11-13 | $26.93M derived: sum of 4 quarters · filed 2018-11-13 | |||||||
| 2017-06-30 | $6.95M 10-Q · filed 2018-08-14 | $12.08M 10-Q · filed 2018-08-14 | $20.86M derived: sum of 3 quarters · filed 2018-08-14 | $26.02M derived: sum of 4 quarters · filed 2018-08-14 | |||||||
| 2017-03-31 | $5.13M 10-Q · filed 2018-05-15 | $13.91M derived: sum of 2 quarters · filed 2018-05-15 | $19.07M derived: sum of 3 quarters · filed 2018-05-15 | $23.23M derived: sum of 4 quarters · filed 2018-05-15 | |||||||
| 2016-12-31 | $8.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $13.94M derived: sum of 2 quarters · filed 2018-04-02 | $18.11M derived: sum of 3 quarters · filed 2018-04-02 | $21.70M 10-K · filed 2018-04-02 | |||||||
| 2016-09-30 | $5.16M 10-Q · filed 2017-11-13 | $9.32M derived: sum of 2 quarters · filed 2017-11-13 | $12.92M 10-Q · filed 2017-11-13 | $16.66M derived: sum of 4 quarters · filed 2017-11-13 | |||||||
| 2016-06-30 | $4.16M 10-Q · filed 2017-08-14 | $7.76M 10-Q · filed 2017-08-14 | $11.50M derived: sum of 3 quarters · filed 2017-08-14 | $13.13M derived: sum of 4 quarters · filed 2017-08-14 | |||||||
| 2016-03-31 | $3.60M 10-Q · filed 2017-05-01 | $7.34M derived: sum of 2 quarters · filed 2017-05-01 | $8.96M derived: sum of 3 quarters · filed 2017-05-01 | $10.13M derived: sum of 4 quarters · filed 2017-05-01 | |||||||
| 2015-12-31 | $3.74M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $5.37M derived: sum of 2 quarters · filed 2017-03-24 | $6.54M derived: sum of 3 quarters · filed 2017-03-24 | $7.66M 10-K · filed 2017-03-24 | |||||||
| 2015-09-30 | $1.62M 10-Q · filed 2016-10-26 | $2.79M derived: sum of 2 quarters · filed 2016-10-26 | $3.92M 10-Q · filed 2016-10-26 | $4.09M derived: sum of 4 quarters · filed 2016-10-26 | |||||||
| 2015-06-30 | $1.17M 10-Q · filed 2016-08-05 | $2.29M 10-Q · filed 2016-08-05 | $2.47M derived: sum of 3 quarters · filed 2016-08-05 | $2.61M derived: sum of 4 quarters · filed 2016-08-05 | |||||||
| 2015-03-31 | $1.13M 10-Q · filed 2016-04-25 | $1.30M derived: sum of 2 quarters · filed 2016-04-25 | $1.44M derived: sum of 3 quarters · filed 2016-04-25 | $2.09M derived: sum of 4 quarters · filed 2016-04-25 | |||||||
| 2014-12-31 | $173.78K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $316.01K derived: sum of 2 quarters · filed 2016-03-30 | $959.57K derived: sum of 3 quarters · filed 2016-03-30 | $961.64K 10-K · filed 2016-03-30 | |||||||
| 2014-09-30 | $142.24K 10-Q · filed 2015-11-16 | $785.79K derived: sum of 2 quarters · filed 2015-11-16 | $787.86K 10-Q · filed 2015-11-16 | ||||||||
| 2014-06-30 | $643.55K 10-Q · filed 2015-08-13 | $645.62K 10-Q · filed 2015-08-13 | |||||||||
| 2014-03-31 | $2.07K 10-Q · filed 2015-05-15 | ||||||||||
| 2014-01-31 | $20.35K 10-Q/A · filed 2014-03-10 | $28.35K 10-Q/A · filed 2014-03-10 | $73.63K 10-Q/A · filed 2014-03-10 | ||||||||
| 2013-12-31 | $24.54K 10-K · filed 2015-03-31 | $26.28K 10-Q · filed 2014-08-28 | |||||||||
| 2013-10-31 | $8.00K 10-Q · filed 2013-12-06 | $53.28K 10-Q · filed 2013-12-06 | |||||||||
| 2013-09-30 | $14.20K 10-Q · filed 2014-10-31 | $22.69K 10-Q · filed 2014-10-31 | |||||||||
| 2013-07-31 | $11.18K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-31 | $21.78K 10-K · filed 2015-03-31 | $45.28K 10-K · filed 2013-10-28 | ||||||||
| 2013-06-30 | $1.76K 10-Q · filed 2014-08-28 | $8.50K 10-Q · filed 2014-08-28 | |||||||||
| 2013-04-30 | $2.40K 10-Q · filed 2013-10-28 | $10.60K 10-Q · filed 2013-10-28 | $34.10K 10-Q · filed 2013-10-28 | ||||||||
| 2013-03-31 | $6.73K 10-Q · filed 2014-08-28 | ||||||||||
| 2013-01-31 | $5.90K 10-Q/A · filed 2014-03-10 | $8.21K 10-Q/A · filed 2014-03-10 | |||||||||
| 2012-12-31 | $2.37K 10-Q · filed 2014-10-31 | ||||||||||
| 2012-10-31 | $1.54K 10-Q · filed 2013-12-06 | ||||||||||
| 2012-07-31 | $15.00K 10-K · filed 2013-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Cronos Group Inc. (CRON) | $1.223B | ||
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |